Measurement of Oxygen Consumption Rate (OCR) and Extracellular Acidification Rate (ECAR) in Culture Cells for Assessment of the Energy Metabolism
Mammalian cells generate ATP by mitochondrial (oxidative phosphorylation) and non-mitochondrial (glycolysis) metabolism. Cancer cells are known to reprogram their metabolism using different strategies to meet energetic and anabolic needs ( Koppenol , 2011 ; Zheng, 2012). Additionally, each cancer ti...
Saved in:
Published in | Bio-protocol Vol. 8; no. 10; p. e2850 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
Bio-Protocol
20.05.2018
Bio-protocol LLC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Mammalian cells generate ATP by mitochondrial (oxidative phosphorylation) and non-mitochondrial (glycolysis) metabolism. Cancer cells are known to reprogram their metabolism using different strategies to meet energetic and anabolic needs ( Koppenol
, 2011 ; Zheng, 2012). Additionally, each cancer tissue has its own individual metabolic features. Mitochondria not only play a key role in energy metabolism but also in cell cycle regulation of cells. Therefore, mitochondria have emerged as a potential target for anticancer therapy since they are structurally and functionally different from their non-cancerous counterparts (D'Souza
, 2011). We detail a protocol for measurement of oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) measurements in living cells, utilizing the Seahorse XF24 Extracellular Flux Analyzer (Figure 1). The Seahorse XF24 Extracellular Flux Analyzer continuously measures oxygen concentration and proton flux in the cell supernatant over time ( Wu
, 2007 ). These measurements are converted in OCR and ECAR values and enable a direct quantification of mitochondrial respiration and glycolysis. With this protocol, we sought to assess basal mitochondrial function and mitochondrial stress of three different cancer cell lines in response to the cytotoxic test lead compound mensacarcin in order to investigate its mechanism of action. Cells were plated in XF24 cell culture plates and maintained for 24 h. Prior to analysis, the culture media was replaced with unbuffered DMEM pH 7.4 and cells were then allowed to equilibrate in a non-CO
incubator immediately before metabolic flux analysis using the Seahorse XF to allow for precise measurements of Milli-pH unit changes. OCR and ECAR were measured under basal conditions and after injection of compounds through drug injection ports. With the described protocol we assess the basic energy metabolism profiles of the three cell lines as well as key parameters of mitochondrial function in response to our test compound and by sequential addition of mitochondria perturbing agents oligomycin, FCCP and rotenone/antimycin A. Figure 1.Overview of seahorse experiment. |
---|---|
AbstractList | Mammalian cells generate ATP by mitochondrial (oxidative phosphorylation) and non-mitochondrial (glycolysis) metabolism. Cancer cells are known to reprogram their metabolism using different strategies to meet energetic and anabolic needs ( Koppenol
, 2011 ; Zheng, 2012). Additionally, each cancer tissue has its own individual metabolic features. Mitochondria not only play a key role in energy metabolism but also in cell cycle regulation of cells. Therefore, mitochondria have emerged as a potential target for anticancer therapy since they are structurally and functionally different from their non-cancerous counterparts (D'Souza
, 2011). We detail a protocol for measurement of oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) measurements in living cells, utilizing the Seahorse XF24 Extracellular Flux Analyzer (Figure 1). The Seahorse XF24 Extracellular Flux Analyzer continuously measures oxygen concentration and proton flux in the cell supernatant over time ( Wu
, 2007 ). These measurements are converted in OCR and ECAR values and enable a direct quantification of mitochondrial respiration and glycolysis. With this protocol, we sought to assess basal mitochondrial function and mitochondrial stress of three different cancer cell lines in response to the cytotoxic test lead compound mensacarcin in order to investigate its mechanism of action. Cells were plated in XF24 cell culture plates and maintained for 24 h. Prior to analysis, the culture media was replaced with unbuffered DMEM pH 7.4 and cells were then allowed to equilibrate in a non-CO
incubator immediately before metabolic flux analysis using the Seahorse XF to allow for precise measurements of Milli-pH unit changes. OCR and ECAR were measured under basal conditions and after injection of compounds through drug injection ports. With the described protocol we assess the basic energy metabolism profiles of the three cell lines as well as key parameters of mitochondrial function in response to our test compound and by sequential addition of mitochondria perturbing agents oligomycin, FCCP and rotenone/antimycin A. Figure 1.Overview of seahorse experiment. Mammalian cells generate ATP by mitochondrial (oxidative phosphorylation) and non-mitochondrial (glycolysis) metabolism. Cancer cells are known to reprogram their metabolism using different strategies to meet energetic and anabolic needs ( Koppenol et al., 2011 ; Zheng, 2012). Additionally, each cancer tissue has its own individual metabolic features. Mitochondria not only play a key role in energy metabolism but also in cell cycle regulation of cells. Therefore, mitochondria have emerged as a potential target for anticancer therapy since they are structurally and functionally different from their non-cancerous counterparts (D'Souza et al., 2011). We detail a protocol for measurement of oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) measurements in living cells, utilizing the Seahorse XF24 Extracellular Flux Analyzer (Figure 1). The Seahorse XF24 Extracellular Flux Analyzer continuously measures oxygen concentration and proton flux in the cell supernatant over time ( Wu et al., 2007 ). These measurements are converted in OCR and ECAR values and enable a direct quantification of mitochondrial respiration and glycolysis. With this protocol, we sought to assess basal mitochondrial function and mitochondrial stress of three different cancer cell lines in response to the cytotoxic test lead compound mensacarcin in order to investigate its mechanism of action. Cells were plated in XF24 cell culture plates and maintained for 24 h. Prior to analysis, the culture media was replaced with unbuffered DMEM pH 7.4 and cells were then allowed to equilibrate in a non-CO2 incubator immediately before metabolic flux analysis using the Seahorse XF to allow for precise measurements of Milli-pH unit changes. OCR and ECAR were measured under basal conditions and after injection of compounds through drug injection ports. With the described protocol we assess the basic energy metabolism profiles of the three cell lines as well as key parameters of mitochondrial function in response to our test compound and by sequential addition of mitochondria perturbing agents oligomycin, FCCP and rotenone/antimycin A. Figure 1.Overview of seahorse experiment.Mammalian cells generate ATP by mitochondrial (oxidative phosphorylation) and non-mitochondrial (glycolysis) metabolism. Cancer cells are known to reprogram their metabolism using different strategies to meet energetic and anabolic needs ( Koppenol et al., 2011 ; Zheng, 2012). Additionally, each cancer tissue has its own individual metabolic features. Mitochondria not only play a key role in energy metabolism but also in cell cycle regulation of cells. Therefore, mitochondria have emerged as a potential target for anticancer therapy since they are structurally and functionally different from their non-cancerous counterparts (D'Souza et al., 2011). We detail a protocol for measurement of oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) measurements in living cells, utilizing the Seahorse XF24 Extracellular Flux Analyzer (Figure 1). The Seahorse XF24 Extracellular Flux Analyzer continuously measures oxygen concentration and proton flux in the cell supernatant over time ( Wu et al., 2007 ). These measurements are converted in OCR and ECAR values and enable a direct quantification of mitochondrial respiration and glycolysis. With this protocol, we sought to assess basal mitochondrial function and mitochondrial stress of three different cancer cell lines in response to the cytotoxic test lead compound mensacarcin in order to investigate its mechanism of action. Cells were plated in XF24 cell culture plates and maintained for 24 h. Prior to analysis, the culture media was replaced with unbuffered DMEM pH 7.4 and cells were then allowed to equilibrate in a non-CO2 incubator immediately before metabolic flux analysis using the Seahorse XF to allow for precise measurements of Milli-pH unit changes. OCR and ECAR were measured under basal conditions and after injection of compounds through drug injection ports. With the described protocol we assess the basic energy metabolism profiles of the three cell lines as well as key parameters of mitochondrial function in response to our test compound and by sequential addition of mitochondria perturbing agents oligomycin, FCCP and rotenone/antimycin A. Figure 1.Overview of seahorse experiment. Mammalian cells generate ATP by mitochondrial (oxidative phosphorylation) and non-mitochondrial (glycolysis) metabolism. Cancer cells are known to reprogram their metabolism using different strategies to meet energetic and anabolic needs ( Koppenol et al. , 2011 ; Zheng, 2012 ). Additionally, each cancer tissue has its own individual metabolic features. Mitochondria not only play a key role in energy metabolism but also in cell cycle regulation of cells. Therefore, mitochondria have emerged as a potential target for anticancer therapy since they are structurally and functionally different from their non-cancerous counterparts (D'Souza et al. , 2011). We detail a protocol for measurement of oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) measurements in living cells, utilizing the Seahorse XF24 Extracellular Flux Analyzer ( Figure 1 ). The Seahorse XF24 Extracellular Flux Analyzer continuously measures oxygen concentration and proton flux in the cell supernatant over time ( Wu et al. , 2007 ). These measurements are converted in OCR and ECAR values and enable a direct quantification of mitochondrial respiration and glycolysis. With this protocol, we sought to assess basal mitochondrial function and mitochondrial stress of three different cancer cell lines in response to the cytotoxic test lead compound mensacarcin in order to investigate its mechanism of action. Cells were plated in XF24 cell culture plates and maintained for 24 h. Prior to analysis, the culture media was replaced with unbuffered DMEM pH 7.4 and cells were then allowed to equilibrate in a non-CO 2 incubator immediately before metabolic flux analysis using the Seahorse XF to allow for precise measurements of Milli-pH unit changes. OCR and ECAR were measured under basal conditions and after injection of compounds through drug injection ports. With the described protocol we assess the basic energy metabolism profiles of the three cell lines as well as key parameters of mitochondrial function in response to our test compound and by sequential addition of mitochondria perturbing agents oligomycin, FCCP and rotenone/antimycin A. Figure 1. Overview of seahorse experiment Mammalian cells generate ATP by mitochondrial (oxidative phosphorylation) and non-mitochondrial (glycolysis) metabolism. Cancer cells are known to reprogram their metabolism using different strategies to meet energetic and anabolic needs (Koppenol et al., 2011; Zheng, 2012). Additionally, each cancer tissue has its own individual metabolic features. Mitochondria not only play a key role in energy metabolism but also in cell cycle regulation of cells. Therefore, mitochondria have emerged as a potential target for anticancer therapy since they are structurally and functionally different from their non-cancerous counterparts (D'Souza et al., 2011). We detail a protocol for measurement of oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) measurements in living cells, utilizing the Seahorse XF24 Extracellular Flux Analyzer (Figure 1). The Seahorse XF24 Extracellular Flux Analyzer continuously measures oxygen concentration and proton flux in the cell supernatant over time (Wu et al., 2007). These measurements are converted in OCR and ECAR values and enable a direct quantification of mitochondrial respiration and glycolysis. With this protocol, we sought to assess basal mitochondrial function and mitochondrial stress of three different cancer cell lines in response to the cytotoxic test lead compound mensacarcin in order to investigate its mechanism of action. Cells were plated in XF24 cell culture plates and maintained for 24 h. Prior to analysis, the culture media was replaced with unbuffered DMEM pH 7.4 and cells were then allowed to equilibrate in a non-CO2 incubator immediately before metabolic flux analysis using the Seahorse XF to allow for precise measurements of Milli-pH unit changes. OCR and ECAR were measured under basal conditions and after injection of compounds through drug injection ports. With the described protocol we assess the basic energy metabolism profiles of the three cell lines as well as key parameters of mitochondrial function in response to our test compound and by sequential addition of mitochondria perturbing agents oligomycin, FCCP and rotenone/antimycin A.Figure 1. Overview of seahorse experiment |
Author | Plitzko, Birte Loesgen, Sandra |
Author_xml | – sequence: 1 givenname: Birte surname: Plitzko fullname: Plitzko, Birte – sequence: 2 givenname: Sandra surname: Loesgen fullname: Loesgen, Sandra |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34285967$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kkFv2yAUgK2p09p1Pe82cewOaQEbbC6TMivbKrXKVG1nBPiRUtkmAzw1P2P_eDRpo3TSTiD43vd4vPe2OBr9CEXxnuALSmouLj87_z345M0FbRh-VZzQsiSzpqTs6GB_XJzFeI8xJiWnhFdviuOyygGC1yfFnxtQcQowwJiQt2j5sFnBiFo_xmlYJ-dHdKsSoPNle_sRqbFDi4cUlIG-n3oV0Ny4zlln1AG6aOeZddky9Sm7UZvpiKzPeIwQ43OydAdoMUJYbdANJKV97-LwrnhtVR_h7Gk9LX5-Wfxov82ul1-v2vn1zFSMpZmtLWXQCCaAE9zwTjONba1rrXUutdYdJqQGZjXjGAi2vOGKYVOTrhKdseVpcbXzdl7dy3Vwgwob6ZWT2wMfVlKF5EwP0igsOOemFNRWHSjRALEVpUx3tBNCZ9ennWs96QE6k-sLqn8hfXkzuju58r9lQ2tGBcmC8ydB8L8miEkOLj5-shrBT1FSxsqG1BWuM_rhMNc-yXNPM3C5A0zwMQawe4RguR0cuR8c-Tg4OYL9E2Fc2nY0P9b1_437C5H2y9U |
CitedBy_id | crossref_primary_10_1016_j_snb_2023_133582 crossref_primary_10_1039_D4SC05393A crossref_primary_10_1016_j_phymed_2021_153674 crossref_primary_10_1038_s41392_024_01954_6 crossref_primary_10_1063_5_0188476 crossref_primary_10_1038_s41698_024_00747_y crossref_primary_10_2147_ITT_S492334 crossref_primary_10_1038_s41420_023_01582_z crossref_primary_10_1186_s40168_024_01872_3 crossref_primary_10_3390_cells11213385 crossref_primary_10_3389_fmolb_2024_1353387 crossref_primary_10_1016_j_crmeth_2023_100642 crossref_primary_10_1016_j_jhazmat_2025_137373 crossref_primary_10_1186_s12872_025_04621_y crossref_primary_10_1002_2211_5463_13765 crossref_primary_10_1021_acschemneuro_2c00709 crossref_primary_10_1016_j_ecoenv_2022_113647 crossref_primary_10_1007_s00204_023_03637_7 crossref_primary_10_1021_acs_est_3c10595 crossref_primary_10_3390_cells11152330 crossref_primary_10_1093_hmg_ddaa071 crossref_primary_10_1093_nar_gkae696 crossref_primary_10_1515_med_2024_1059 crossref_primary_10_1016_j_mito_2023_08_001 crossref_primary_10_3390_antiox8100432 crossref_primary_10_4081_ejh_2023_3528 crossref_primary_10_1016_j_jare_2023_11_014 crossref_primary_10_1016_j_phrs_2023_106980 crossref_primary_10_1128_aac_01941_21 crossref_primary_10_1021_acschembio_1c00807 crossref_primary_10_1007_s12035_024_04148_x crossref_primary_10_1038_s44259_024_00042_7 crossref_primary_10_1080_02713683_2024_2355661 crossref_primary_10_1016_j_adcanc_2022_100070 crossref_primary_10_1016_j_jhazmat_2023_132570 crossref_primary_10_1186_s12967_020_02672_7 crossref_primary_10_21769_BioProtoc_4321 crossref_primary_10_1038_s41556_024_01588_4 crossref_primary_10_1007_s10616_019_00334_1 crossref_primary_10_2131_jts_48_87 crossref_primary_10_18632_aging_206207 crossref_primary_10_2139_ssrn_4162511 crossref_primary_10_1007_s43188_023_00183_3 crossref_primary_10_1016_j_bmc_2024_117897 crossref_primary_10_3389_ti_2024_12330 crossref_primary_10_1158_0008_5472_CAN_23_2700 crossref_primary_10_3390_pharmaceutics17030365 crossref_primary_10_1016_j_biopha_2024_116981 crossref_primary_10_3390_ijms23136887 crossref_primary_10_15283_ijsc23167 crossref_primary_10_1016_j_fsi_2024_109926 crossref_primary_10_1016_j_taap_2024_117064 crossref_primary_10_3390_biom11081177 crossref_primary_10_1016_j_electacta_2024_144798 crossref_primary_10_1016_j_freeradbiomed_2023_05_023 crossref_primary_10_1038_s41392_023_01499_0 crossref_primary_10_1080_15384101_2023_2247248 crossref_primary_10_1080_15287394_2023_2292709 crossref_primary_10_1002_jcb_28448 crossref_primary_10_1073_pnas_2409509121 crossref_primary_10_3390_ijms24097836 crossref_primary_10_1016_j_isci_2022_105670 crossref_primary_10_1111_pce_15185 crossref_primary_10_3390_cells10020304 crossref_primary_10_1186_s12951_022_01391_z crossref_primary_10_3390_ijms21228711 crossref_primary_10_1038_s41467_024_46415_4 crossref_primary_10_1021_acsnano_4c09971 crossref_primary_10_1152_ajpcell_00130_2023 crossref_primary_10_1007_s13167_022_00281_6 crossref_primary_10_1111_jcmm_18085 crossref_primary_10_1021_acs_estlett_2c00431 crossref_primary_10_3390_biomedicines13010107 crossref_primary_10_1016_j_vph_2024_107372 crossref_primary_10_1021_acsomega_3c09025 crossref_primary_10_4049_immunohorizons_2400045 crossref_primary_10_1016_j_dnarep_2019_102675 crossref_primary_10_1038_s41598_023_50877_9 crossref_primary_10_1016_j_freeradbiomed_2023_07_035 crossref_primary_10_1186_s40170_024_00353_3 crossref_primary_10_1016_j_mce_2021_111484 crossref_primary_10_1186_s12935_023_02974_y crossref_primary_10_1021_acs_molpharmaceut_4c00269 crossref_primary_10_1038_s41596_019_0231_x crossref_primary_10_3390_fishes7060354 crossref_primary_10_1016_j_abb_2023_109559 crossref_primary_10_1016_j_comtox_2021_100191 crossref_primary_10_1016_j_fct_2021_112214 crossref_primary_10_4252_wjsc_v14_i1_1 |
Cites_doi | 10.1074/jbc.M116.774836 10.1016/B978-0-12-416618-9.00005-4 10.1016/j.bbabio.2010.08.008 10.1007/978-1-61779-504-6_5 10.1016/j.bcp.2014.11.015 10.3892/ol.2012.928 10.1152/ajpcell.00247.2006 10.1038/nrc3038 |
ContentType | Journal Article |
Copyright | Copyright © 2018 The Authors; exclusive licensee Bio-protocol LLC. Copyright © 2018 The Authors; exclusive licensee Bio-protocol LLC. 2018 |
Copyright_xml | – notice: Copyright © 2018 The Authors; exclusive licensee Bio-protocol LLC. – notice: Copyright © 2018 The Authors; exclusive licensee Bio-protocol LLC. 2018 |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.21769/BioProtoc.2850 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ (Directory of Open Access Journals) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2331-8325 |
ExternalDocumentID | oai_doaj_org_article_ca09666c392f4dea98e1f4225bd2d99b PMC8275291 34285967 10_21769_BioProtoc_2850 |
Genre | Journal Article |
GroupedDBID | 53G AAYXX ALMA_UNASSIGNED_HOLDINGS CITATION FRP GROUPED_DOAJ M~E OK1 RPM NPM 7X8 5PM |
ID | FETCH-LOGICAL-c455t-f7f25e8959e61086db5b0f7b7bbb0017bd0117e5fb560e10f686a50c71d49dcf3 |
IEDL.DBID | DOA |
ISSN | 2331-8325 |
IngestDate | Wed Aug 27 01:30:13 EDT 2025 Thu Aug 21 17:36:47 EDT 2025 Fri Jul 11 15:51:56 EDT 2025 Thu Jan 02 22:55:22 EST 2025 Tue Jul 01 03:41:36 EDT 2025 Thu Apr 24 22:59:07 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | Glycolysis Mitochondrial respiration Mitochondrial metabolism Bioenergetics Seahorse XF |
Language | English |
License | Copyright © 2018 The Authors; exclusive licensee Bio-protocol LLC. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c455t-f7f25e8959e61086db5b0f7b7bbb0017bd0117e5fb560e10f686a50c71d49dcf3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doaj.org/article/ca09666c392f4dea98e1f4225bd2d99b |
PMID | 34285967 |
PQID | 2553817407 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_ca09666c392f4dea98e1f4225bd2d99b pubmedcentral_primary_oai_pubmedcentral_nih_gov_8275291 proquest_miscellaneous_2553817407 pubmed_primary_34285967 crossref_primary_10_21769_BioProtoc_2850 crossref_citationtrail_10_21769_BioProtoc_2850 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-05-20 |
PublicationDateYYYYMMDD | 2018-05-20 |
PublicationDate_xml | – month: 05 year: 2018 text: 2018-05-20 day: 20 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: 1075 Lorne Way, Sunnyvale, CA 94087, USA |
PublicationTitle | Bio-protocol |
PublicationTitleAlternate | Bio Protoc |
PublicationYear | 2018 |
Publisher | Bio-Protocol Bio-protocol LLC |
Publisher_xml | – name: Bio-Protocol – name: Bio-protocol LLC |
References | ref2323 ref2324 ref2325 ref2330 ref2326 ref2327 ref2328 ref2329 |
References_xml | – ident: ref2326 doi: 10.1074/jbc.M116.774836 – ident: ref2328 doi: 10.1016/B978-0-12-416618-9.00005-4 – ident: ref2323 doi: 10.1016/j.bbabio.2010.08.008 – ident: ref2325 doi: 10.1007/978-1-61779-504-6_5 – ident: ref2327 doi: 10.1016/j.bcp.2014.11.015 – ident: ref2330 doi: 10.3892/ol.2012.928 – ident: ref2329 doi: 10.1152/ajpcell.00247.2006 – ident: ref2324 doi: 10.1038/nrc3038 |
SSID | ssj0001362164 |
Score | 2.403242 |
Snippet | Mammalian cells generate ATP by mitochondrial (oxidative phosphorylation) and non-mitochondrial (glycolysis) metabolism. Cancer cells are known to reprogram... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | e2850 |
SubjectTerms | Biology Methods |
Title | Measurement of Oxygen Consumption Rate (OCR) and Extracellular Acidification Rate (ECAR) in Culture Cells for Assessment of the Energy Metabolism |
URI | https://www.ncbi.nlm.nih.gov/pubmed/34285967 https://www.proquest.com/docview/2553817407 https://pubmed.ncbi.nlm.nih.gov/PMC8275291 https://doaj.org/article/ca09666c392f4dea98e1f4225bd2d99b |
Volume | 8 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYqTr1URS1lS4uMxAEOgTxsJz4u0SJUiYdQkbhFfqqRIEG7QaI_g3_MjLOELGrFhWsySSzPF883o_FnQnYzb4vY6yRKfcoj5oSMdMx8BLGWyQRBYoLa55k4uWK_rvn16Kgv7Anr5YH7iTs0Cki2EAbiuGfWKVm4xDNAobaplVLj6gsxb5RMheoKrMuQCPRaPsC6hTw8qtuLedu15iAtcJf9KAwFtf5_UczXnZKj0HP8mXxackY67ce6Tj645gt5PH2p7tHW0_OHv4AFWoYtlWEdoJfAI-neeXm5T1Vj6ewBXo6Feuw8pVNTW2wTUiPTWTkF2xreEvQ4HC3BekGB19LpoOCJHwPWSGdh1yA9dR3g6KZe3H4lV8ez3-VJtDxfITKM8y7yOfjHFZJLJ_DAJau5jn2uc61DbqgtCsY57jXQIpfEXhRC8djkiWXSGp9tkLWmbdwmobl1uWJFwri1WKvTsfRKcJVom2UuNhNy8DzdlVmKj-MZGDcVJCHBP9Xgnwr9MyF7wwN3ve7G_02P0H-DGQpmhwsAo2oJo-otGE3IzrP3K_jB0Bmqce39ooKcC1UMIfGdkG89GoZPZQz1_wTcyVdwsjKW1TtN_SeIeBdpzlOZfH-PwW-Rj8DjCmxqSOMfZK2b37ufwJU6vR1-i-1QxHoCoYYX8Q |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Measurement+of+Oxygen+Consumption+Rate+%28OCR%29+and+Extracellular+Acidification+Rate+%28ECAR%29+in+Culture+Cells+for+Assessment+of+the+Energy+Metabolism&rft.jtitle=Bio-protocol&rft.au=Birte+Plitzko&rft.au=Sandra+Loesgen&rft.date=2018-05-20&rft.pub=Bio-protocol+LLC&rft.eissn=2331-8325&rft.volume=8&rft.issue=10&rft_id=info:doi/10.21769%2FBioProtoc.2850&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_ca09666c392f4dea98e1f4225bd2d99b |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2331-8325&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2331-8325&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2331-8325&client=summon |